CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-10 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −220 | $0.37 | $81 | 32,605 |
| 2023-07-10 | Mitrano Richard J. VP Finance & Operations | Option exercise 10b5-1 | +758 | 33,363 | ||
| 2023-07-10 | Mitrano Richard J. VP Finance & Operations | Option exercise · Restricted Stock Unit 10b5-1 | −758 | 21,968 | ||
| 2023-07-10 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,591 | $0.38 | $985 | 442,696 |
| 2023-07-10 | Lucchino David L. President and CEO | Option exercise 10b5-1 | +9,091 | 451,787 | ||
| 2023-07-10 | Lucchino David L. President and CEO | Option exercise · Restricted Stock Unit 10b5-1 | −9,091 | 263,636 | ||
| 2023-07-07 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −220 | $0.36 | $79 | 55,551 |
| 2023-07-07 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,634 | $0.35 | $922 | 718,014 |
| 2023-07-07 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,306 | $0.36 | $470 | 203,689 |
| 2023-07-07 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,306 | $0.36 | $470 | 62,781 |
| 2023-07-07 | Loose Christopher R. Chief Scientific Officer | Option exercise 10b5-1 | +4,546 | 67,327 | ||
| 2023-07-07 | Loose Christopher R. Chief Scientific Officer | Option exercise · Restricted Stock Unit 10b5-1 | −4,546 | 136,362 | ||
| 2023-07-07 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −220 | $0.36 | $79 | 32,067 |
| 2023-07-07 | Mitrano Richard J. VP Finance & Operations | Option exercise 10b5-1 | +758 | 32,825 | ||
| 2023-07-07 | Mitrano Richard J. VP Finance & Operations | Option exercise · Restricted Stock Unit 10b5-1 | −758 | 22,726 | ||
| 2023-07-07 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,634 | $0.35 | $922 | 436,196 |
| 2023-07-07 | Lucchino David L. President and CEO | Option exercise 10b5-1 | +9,091 | 445,287 | ||
| 2023-07-07 | Lucchino David L. President and CEO | Option exercise · Restricted Stock Unit 10b5-1 | −9,091 | 272,727 | ||
| 2023-07-06 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −224 | $0.35 | $78 | 55,771 |
| 2023-07-06 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,773 | $0.34 | $943 | 720,648 |
Page 14 of 23 · 441 trades